Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine.

Kunos CA, Coleman CN.

Int J Radiat Oncol Biol Phys. 2018 Jan 8. pii: S0360-3016(17)30644-2. doi: 10.1016/j.ijrobp.2017.02.225. [Epub ahead of print] No abstract available.

PMID:
29325810
2.

Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.

Aryankalayil MJ, Chopra S, Levin J, Eke I, Makinde A, Das S, Shankavaram U, Vanpouille-Box C, Demaria S, Coleman CN.

Radiat Res. 2018 Jan 8. doi: 10.1667/RR14891.1. [Epub ahead of print]

PMID:
29309266
3.

Treatment, Not Terror: Time for Unique Problem-Solving Partnerships for Cancer Care in Resource-Challenged Environments.

Coleman CN, Pomper MA, Chao N, Dalnoki-Veress F, Pistenmaa DA.

J Glob Oncol. 2017 Dec;3(6):687-691. doi: 10.1200/JGO.2016.007591. Epub 2017 Jan 11. No abstract available.

4.

Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY.

Int J Radiat Oncol Biol Phys. 2017 Jun 9. pii: S0360-3016(17)30982-3. doi: 10.1016/j.ijrobp.2017.05.044. [Epub ahead of print]

PMID:
28964588
5.

Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example.

Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN.

Mol Cancer Ther. 2018 Feb;17(2):355-367. doi: 10.1158/1535-7163.MCT-17-0262. Epub 2017 Aug 11.

PMID:
28802252
6.

The Call.

Coleman CN.

Pract Radiat Oncol. 2018 Jan - Feb;8(1):1-3. doi: 10.1016/j.prro.2017.05.006. Epub 2017 May 25. No abstract available.

PMID:
28676227
7.

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S.

Nat Commun. 2017 Jun 9;8:15618. doi: 10.1038/ncomms15618.

8.

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.

Kunos CA, Galanis E, Buchsbaum J, Shi Q, Strauss LC, Coleman CN, Ahmed MM.

J Neurooncol. 2017 Sep;134(3):551-557. doi: 10.1007/s11060-017-2458-0. Epub 2017 May 30. Review.

PMID:
28560665
9.

Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Citrin DE, Prasanna PGS, Walker AJ, Freeman ML, Eke I, Barcellos-Hoff MH, Arankalayil MJ, Cohen EP, Wilkins RC, Ahmed MM, Anscher MS, Movsas B, Buchsbaum JC, Mendonca MS, Wynn TA, Coleman CN.

Radiat Res. 2017 Jul;188(1):1-20. doi: 10.1667/RR14784.1. Epub 2017 May 10.

PMID:
28489488
10.

Implementing Cancer Care for the Undeserved Globally: From the "5 R's" of Radiobiology to the "7 P's" of Global Cancer Care.

Williams TR, Coleman CN.

Semin Radiat Oncol. 2017 Apr;27(2):95-97. doi: 10.1016/j.semradonc.2016.11.012. Epub 2016 Nov 24. No abstract available.

PMID:
28325247
11.

Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress.

Guadagnolo BA, Petereit DG, Coleman CN.

Semin Radiat Oncol. 2017 Apr;27(2):143-149. doi: 10.1016/j.semradonc.2016.11.006. Epub 2016 Nov 24. Review.

PMID:
28325240
12.

Global Health in Radiation Oncology: The Emergence of a New Career Pathway.

Rodin D, Yap ML, Grover S, Longo JM, Balogun O, Turner S, Eriksen JG, Coleman CN, Giuliani M.

Semin Radiat Oncol. 2017 Apr;27(2):118-123. doi: 10.1016/j.semradonc.2016.11.003. Epub 2016 Nov 9. Review.

PMID:
28325237
13.

The Radiation Stress Response: Of the People, By the People and For the People.

Coleman CN.

Radiat Res. 2017 Feb;187(2):129-146. doi: 10.1667/RR0CNC.1. Epub 2017 Jan 24.

14.

Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care.

Rodin D, Longo J, Sherertz T, Shah MM, Balagun O, Wendling N, Van Dyk J, Coleman CN, Xu MJ, Grover S.

Clin Oncol (R Coll Radiol). 2017 Feb;29(2):135-140. doi: 10.1016/j.clon.2016.11.008. Epub 2016 Dec 9.

PMID:
27955997
15.

Radiotherapy: Changing the Game in Immunotherapy.

Demaria S, Coleman CN, Formenti SC.

Trends Cancer. 2016 Jun;2(6):286-294. Review.

16.

Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.

Eke I, Makinde AY, Aryankalayil MJ, Ahmed MM, Coleman CN.

Cancer Lett. 2016 Nov 1;382(1):118-126. doi: 10.1016/j.canlet.2016.01.041. Epub 2016 Jan 29. Review.

17.

Masters of Our Destiny: From Jazz Quartet to Symphony Orchestra.

Coleman CN.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):511-3. doi: 10.1016/j.ijrobp.2016.07.006. No abstract available.

PMID:
27681746
18.

Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.

Makinde AY, Eke I, Aryankalayil MJ, Ahmed MM, Coleman CN.

Semin Radiat Oncol. 2016 Oct;26(4):254-60. doi: 10.1016/j.semradonc.2016.07.001. Epub 2016 Jul 5. Review.

19.

Current Insights in Radiation Combination Therapies: Influence of Omics and Novel Targeted Agents in Defining New Concepts in Radiation Biology and Clinical Radiation Oncology.

Ahmed MM, Narendra A, Prasanna P, Coleman CN, Krishnan S.

Semin Radiat Oncol. 2016 Oct;26(4):251-3. doi: 10.1016/j.semradonc.2016.07.002. Epub 2016 Jul 5. No abstract available.

PMID:
27619246
20.

Biodosimetry: Medicine, Science, and Systems to Support the Medical Decision-Maker Following a Large Scale Nuclear or Radiation Incident.

Coleman CN, Koerner JF.

Radiat Prot Dosimetry. 2016 Dec;172(1-3):38-46. doi: 10.1093/rpd/ncw155. Epub 2016 Jul 29.

PMID:
27473694
21.

Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C.

J Natl Cancer Inst. 2016 Jul 4;108(9). pii: djw133. doi: 10.1093/jnci/djw133. Print 2016 Sep. Review.

PMID:
27377923
22.

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM.

Clin Cancer Res. 2016 Jul 1;22(13):3138-47. doi: 10.1158/1078-0432.CCR-16-0069. Epub 2016 May 6. Review.

23.

Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations.

Stone HB, Bernhard EJ, Coleman CN, Deye J, Capala J, Mitchell JB, Brown JM.

Transl Oncol. 2016 Feb;9(1):46-56. doi: 10.1016/j.tranon.2016.01.002. Review.

24.

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24. Review.

25.

A Roadmap for a New Academic Pathway for Global Radiation Oncology.

Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):493-6. doi: 10.1016/j.ijrobp.2015.06.023. No abstract available.

PMID:
26460990
26.

The verdict is in: the time for effective solutions to the global cancer burden is now.

Coleman CN, Minsky BD.

Lancet Oncol. 2015 Sep;16(10):1146-7. doi: 10.1016/S1470-2045(15)00276-4. No abstract available.

PMID:
26419350
27.

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Prasanna PG, Narayanan D, Hallett K, Bernhard EJ, Ahmed MM, Evans G, Vikram B, Weingarten M, Coleman CN.

Radiat Res. 2015 Sep;184(3):235-48. doi: 10.1667/RR14186.1. Epub 2015 Aug 18.

28.

Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem".

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM.

Front Oncol. 2015 Jun 10;5:133. doi: 10.3389/fonc.2015.00133. eCollection 2015.

29.

Editorial: "global challenges in radiation oncology".

Petereit DG, Coleman CN.

Front Oncol. 2015 May 15;5:103. doi: 10.3389/fonc.2015.00103. eCollection 2015. No abstract available.

30.

Training global oncologists: addressing the global cancer control problem.

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM.

Front Oncol. 2015 Apr 8;5:80. doi: 10.3389/fonc.2015.00080. eCollection 2015. Review. No abstract available. Erratum in: Front Oncol. 2015;5:133.

31.

Nuclear and radiological security and safety (program area committees 3 & 5)-session Q&A.

Coleman CN, Chen SY.

Health Phys. 2015 Feb;108(2):170-1. doi: 10.1097/HP.0000000000000248. No abstract available.

PMID:
25551498
32.

Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise.

Coleman CN, Sullivan JM, Bader JL, Murrain-Hill P, Koerner JF, Garrett AL, Weinstock DM, Case C Jr, Hrdina C, Adams SA, Whitcomb RC, Graeden E, Shankman R, Lant T, Maidment BW, Hatchett RC.

Health Phys. 2015 Feb;108(2):149-60. doi: 10.1097/HP.0000000000000249.

33.

The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B.

Front Oncol. 2014 Nov 19;4:333. doi: 10.3389/fonc.2014.00333. eCollection 2014. Review.

34.

National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned.

Wong RS, Vikram B, Govern FS, Petereit DG, Maguire PD, Clarkson MR, Heron DE, Coleman CN.

Front Oncol. 2014 Nov 3;4:303. doi: 10.3389/fonc.2014.00303. eCollection 2014.

35.

Transforming science, service, and society.

Coleman CN, Love RR.

Sci Transl Med. 2014 Oct 22;6(259):259fs42. doi: 10.1126/scitranslmed.3009640.

PMID:
25338753
36.

Combining targeted agents with modern radiotherapy in soft tissue sarcomas.

Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D.

J Natl Cancer Inst. 2014 Oct 18;106(11). pii: dju329. doi: 10.1093/jnci/dju329. Print 2014 Nov. Review.

37.

Enhancing the efficacy of radiation therapy: premises, promises, and practicality.

Coleman CN, Lawrence TS, Kirsch DG.

J Clin Oncol. 2014 Sep 10;32(26):2832-5. doi: 10.1200/JCO.2014.57.3865. Epub 2014 Aug 11. No abstract available.

38.

Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.

Aryankalayil MJ, Makinde AY, Gameiro SR, Hodge JW, Rivera-Solis PP, Palayoor ST, Ahmed MM, Coleman CN.

Radiat Res. 2014 Aug;182(2):139-48. doi: 10.1667/RR13731.1. Epub 2014 Jul 8.

39.

The medical student perspective on global health care in radiation oncology: opportunities, barriers to sustainability, and future directions.

Burkeen J, Coleman CN, Daphtary M, Vikram B.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):492-4. doi: 10.1016/j.ijrobp.2013.10.013. No abstract available.

PMID:
24929160
40.

Bringing cancer care to the underserved globally: a challenging problem for which radiation oncology can pioneer novel solutions.

Coleman CN; many others.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):443-5. doi: 10.1016/j.ijrobp.2014.04.002. No abstract available.

PMID:
24929152
41.

Radiation-induced brain damage, impact of Michael Robbins' work and the need for predictive biomarkers.

Prasanna PG, Ahmed MM, Stone HB, Vikram B, Mehta MP, Coleman CN.

Int J Radiat Biol. 2014 Sep;90(9):742-52. doi: 10.3109/09553002.2014.925607. Epub 2014 Jun 25. Review.

PMID:
24844376
42.

Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.

Palayoor ST, John-Aryankalayil M, Makinde AY, Falduto MT, Magnuson SR, Coleman CN.

Mol Cancer Res. 2014 Jul;12(7):1002-15. doi: 10.1158/1541-7786.MCR-13-0623. Epub 2014 Apr 30.

43.

Harnessing the potential of radiation-induced immune modulation for cancer therapy.

Ahmed MM, Hodge JW, Guha C, Bernhard EJ, Vikram B, Coleman CN.

Cancer Immunol Res. 2013 Nov;1(5):280-4. doi: 10.1158/2326-6066.CIR-13-0141. Review.

44.

The medical decision model and decision maker tools for management of radiological and nuclear incidents.

Koerner JF, Coleman CN, Murrain-Hill P, FitzGerald DJ, Sullivan JM.

Health Phys. 2014 Jun;106(6):645-51. doi: 10.1097/HP.0000000000000053.

PMID:
24776895
45.

Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.

Yoo SS, Jorgensen TJ, Kennedy AR, Boice JD Jr, Shapiro A, Hu TC, Moyer BR, Grace MB, Kelloff GJ, Fenech M, Prasanna PG, Coleman CN.

J Radiol Prot. 2014 Jun;34(2):R25-52. doi: 10.1088/0952-4746/34/2/R25. Epub 2014 Apr 14. Review.

PMID:
24727460
46.

Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Prasanna A, Ahmed MM, Mohiuddin M, Coleman CN.

J Thorac Dis. 2014 Apr;6(4):287-302. doi: 10.3978/j.issn.2072-1439.2014.01.14. Review.

47.

Recovery and resilience after a nuclear power plant disaster: a medical decision model for managing an effective, timely, and balanced response.

Coleman CN, Blumenthal DJ, Casto CA, Alfant M, Simon SL, Remick AL, Gepford HJ, Bowman T, Telfer JL, Blumenthal PM, Noska MA.

Disaster Med Public Health Prep. 2013 Apr;7(2):136-45. doi: 10.1017/dmp.2013.5.

PMID:
24618164
48.

Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations.

Sullivan JM, Prasanna PG, Grace MB, Wathen LK, Wallace RL, Koerner JF, Coleman CN.

Health Phys. 2013 Dec;105(6):540-54. doi: 10.1097/HP.0b013e31829cf221.

49.

mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.

Simone CB 2nd, John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN.

Transl Oncol. 2013 Oct 1;6(5):573-85. eCollection 2013.

50.

Lessons learned from radiation oncology clinical trials.

Liu FF; workshop participants, Okunieff P, Bernhard EJ, Stone HB, Yoo S, Coleman CN, Vikram B, Brown M, Buatti J, Guha C.

Clin Cancer Res. 2013 Nov 15;19(22):6089-100. doi: 10.1158/1078-0432.CCR-13-1116. Epub 2013 Sep 16. Review.

Supplemental Content

Loading ...
Support Center